A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a pathway-targeted therapy ...

"While patients at risk of frailty and limited life expectancy are common in our population, these measures do not appear to significantly influence patient and clinician treatment decision making." — ...

Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...

HER2-directed therapies, including monoclonal antibodies, ADCs, and TKIs, have improved survival in HER2-positive breast cancer patients. Clinical trials like CLEOPATRA, DESTINY-Breast01, and ...

At the ASCO annual meeting, Dana-Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously ...

EMA fast tracks review of a medicine for metastatic pancreatic cancer: Amsterdam, The Netherlands Thursday, July 9, 2026, 12:00 Hrs [IST] European Medicines Agency’s (EMA) human ...

July 7 () - The European Medicines Agency said on Tuesday it has begun a rolling review of Revolution ‌Medicines' ...